Blue Ridge Anesthesia & Critical Care, Inc. v. Gidick
Facts
Blue Ridge sold anesthesia and critical care equipment in a highly competitive market and hired Gidick, Ward, and Faupel under employment contracts containing a three-year non-competition agreement. The covenant barred each employee, after 90 days of employment, from opening, working for, or acting on behalf of a competitor rendering the same or similar services within the territories serviced by that employee, but did not preclude work in the medical industry in a non-competing role. During employment, Gidick worked only as a salesman, while Ward and Faupel were primarily servicemen who sometimes engaged in sales, and all had customer contact in their territories. After leaving Blue Ridge, Gidick began selling the same type of equipment in his former territory, and Ward and Faupel joined Sarah Medical, a company formed by Gidick.
Issue
Whether the employees' non-competition agreement was valid and enforceable. More specifically, the question was whether the covenant was reasonable as to Blue Ridge's legitimate business interests, the employees' ability to earn a livelihood, and public policy.
Rule
An employer-employee non-competition agreement is valid if, in light of the facts of the case, the restraint is no greater than necessary to protect the employer's legitimate business interest, is not unduly harsh and oppressive in curtailing the employee's legitimate efforts to earn a livelihood, and is reasonable from the standpoint of sound public policy. Such agreements may be justified by employee contact with customers even if the employee did not possess confidential information or trade secrets.
See the holding & full analysis
Create a free KwikCourt account to unlock the rest of this brief — and practice the case.
- The court's holding and reasoning
- Doctrine tests, pitfalls & exam hypotheticals
- 10 practice questions + 4 AI-graded essays on this case
Test yourself
If Lena argues the covenant is unenforceable because she never handled trade secrets or confidential pricing data, what is the strongest response?